Intensified therapy improves outcomes for childhood B-cell acute lymphoblastic leukemia subgroup

Intensifying therapy significantly improved OS and reduced the risk for relapse among children with childhood B-cell acute lymphoblastic leukemia and IKZF1 deletion, study data showed.

Read more: https://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Babbd787a-b112-4c98-a812-d3070ad3af83%7D/intensified-therapy-improves-outcomes-for-childhood-b-cell-acute-lymphoblastic-leukemia-subgroup